方盛制药(603998.SH)：上半年净利润同比增长23.67% 拟10股派1.5元

Core Viewpoint - Fangsheng Pharmaceutical (603998.SH) reported a decline in revenue for the first half of the year, while net profit showed significant growth [1] Financial Performance - The company achieved operating revenue of 834.25 million yuan, a year-on-year decrease of 8.35% [1] - The net profit attributable to shareholders of the listed company was 169.24 million yuan, reflecting a year-on-year increase of 23% [1]